Tag

Addiction Treatment

All articles tagged with #addiction treatment

health1 month ago•5 min saved

Months-Long Shield Against Fentanyl: San Francisco's Breakthrough Addiction Therapy

San Francisco is expanding long-acting injectable buprenorphine to treat fentanyl addiction, a therapy that blocks opioids for weeks and has shown higher retention than daily meds: the city logged about 1,400 injections in 2024 and 2,800 in 2025, with jail programs reporting 43% follow-up after release versus 29% for daily-pill users. While promising, the first dose can cause intense withdrawal if dosing is not precise, and some patients still relapse. Experts view this as a major breakthrough that could widen access beyond SF as research continues.

via sfstandard.com|

#addiction-treatment #buprenorphine #fentanyl

healthcare1 month ago•19 min saved

Overdose Surge in Flathead County Strains Resources and Families

The article discusses the rising overdose crisis in Flathead County, Montana, driven by fentanyl and poly-drug use, highlighting personal stories like Riley McConnell's, and emphasizing the need for increased awareness, resources, and community intervention to combat the growing opioid epidemic.

via Flathead Beacon|

#addiction-treatment #fentanyl #healthcare

health-and-wellness1 month ago•1 min saved

Jelly Roll's Remarkable 275-Pound Weight Loss Journey

Country singer Jelly Roll lost over 270 pounds by treating his overeating as an addiction, similar to his past struggles with substance abuse, which significantly improved his mental health and overall lifestyle.

via Yahoo|

#addiction-treatment #health-and-wellness #jelly-roll

health2 months ago•5 min saved

LGBTQ+ Recovery Community Faces Setback After Pride Institute Closure

The Pride Institute, a longstanding LGBTQ+ focused addiction treatment center in Minnesota, is closing its inpatient program due to financial challenges and changes in the treatment landscape, leading to layoffs and concerns about reduced access to specialized care for vulnerable LGBTQ+ individuals.

via MPR News|

#addiction-treatment #health #lgbtq

health2 months ago•4 min saved

Overdose Deaths Decline Stalls as New Dashboard Tracks Rebound

Overdose deaths in the U.S. are declining due to expanded access to medications, telehealth, and community programs, but this progress is at risk if Congress does not act to preserve and expand these policies in 2026.

via Salon.com|

#addiction-treatment #health #medicaid

health2 months ago•8 min saved

Potential of GLP-1 Obesity Drugs in Treating Addiction and Alcohol Use Disorders

Research suggests that blockbuster obesity drugs like semaglutide may have potential in treating addiction by acting on brain pathways related to reward and craving, with ongoing clinical trials exploring their efficacy for alcohol, nicotine, and opioid dependence, potentially revolutionizing addiction medicine.

via Nature|

#addiction-treatment #drug-repurposing #glp-1

health-and-science4 months ago•2 min saved

Doctors Discover Surprising Effects of Drinking on Ozempic

Recent research suggests that GLP-1 drugs like Ozempic not only aid weight loss but also reduce alcohol cravings and alter alcohol processing in the body by slowing gastric emptying, which delays alcohol absorption and effects. This could have implications for addiction treatment, though further studies are needed to understand the mechanisms involved.

via Futurism|

#addiction-treatment #alcohol-cravings #gastric-emptying

health4 months ago•4 min saved

Ozempic and Wegovy May Reduce Alcohol Cravings and Consumption

Scientists have found that GLP-1 receptor agonists like Ozempic slow alcohol absorption and reduce intoxication, potentially lowering alcohol's addictive potential by delaying its entry into the bloodstream, which could have implications for treating alcohol use disorder.

via ZME Science|

#addiction-treatment #alcohol-absorption #blood-alcohol-levels

health4 months ago•2 min saved

Weight Loss Drugs and Their Potential to Reduce Alcohol Consumption

Research from Virginia Tech suggests that weight loss drugs, specifically GLP-1 agonists, delay alcohol absorption, reducing the immediate effects and potentially helping people cut back on drinking, which could be beneficial for alcohol use disorder treatment.

via WTOP|

#addiction-treatment #alcohol-absorption #glp-1-agonists

health6 months ago•3 min saved

Quitting Smoking Enhances Recovery from Other Addictions

A study funded by NIH found that adults who quit smoking are more likely to recover from other substance use disorders, highlighting the importance of integrating smoking cessation into addiction treatment programs.

via National Institutes of Health (NIH) | (.gov)|

#addiction-treatment #health #nih

health7 months ago•3 min saved

Gallatin County Faces Worsening Substance Abuse Crisis

Gallatin County, Montana, known as the 'drunkest county in America,' faces a severe substance abuse crisis with high rates of heavy drinking, increasing alcohol-related deaths, and strained addiction resources, reflecting a culture that heavily relies on chemical dependency as a coping mechanism.

via KBZK News|

#addiction-treatment #alcohol-related-deaths #culture

health1 year ago•7 min saved

GLP-1 Diabetes Drugs Show Promise in Reducing Alcohol Consumption

GLP-1 receptor agonist drugs like Ozempic, initially used for weight loss, are showing potential in reducing cravings for alcohol and other substances. Studies indicate that these drugs may lower the risk of alcohol use disorder and reduce nicotine and opioid overuse by influencing dopamine pathways in the brain. While not yet approved for treating substance use disorders, these drugs could revolutionize addiction treatment if further research supports their efficacy. Experts are hopeful that GLP-1 drugs could become a major tool in addiction therapy, similar to how SSRIs transformed depression treatment.

via National Geographic|

#addiction-treatment #alcohol-use-disorder #glp-1-drugs

health-policy1 year ago•5 min saved

"Shift Focus to Treatment Over Criminalization for Addiction Recovery"

Nora Volkow, director of the National Institute on Drug Abuse, advocates for shifting U.S. drug policy from criminalization to treatment-focused approaches, particularly for incarcerated individuals. She emphasizes the need for medication-assisted treatment to combat the opioid crisis and reduce recidivism, highlighting the public health and safety benefits. Volkow criticizes the current system for exacerbating inequalities and calls for proactive measures to address addiction and mental health needs.

via Marijuana Moment|

#addiction-treatment #criminal-justice-reform #drug-policy

health1 year ago•6 min saved

"New Opioid Treatment Policy Embraces Alternatives to Abstinence"

The Biden administration is shifting federal addiction treatment policies to acknowledge that while total abstinence is ideal, reducing drug use can also significantly lower risks and improve outcomes. This approach aligns with harm reduction strategies and aims to support patients who may not achieve complete abstinence but can still benefit from reduced use. Key federal agencies, including NIDA, SAMHSA, and the FDA, are updating guidelines and regulations to reflect this more flexible and pragmatic stance on addiction treatment.

via STAT|

#addiction-treatment #biden-administration #federal-policy

health1 year ago•5 min saved

"Semaglutide's Potential in Treating Cannabis Dependence"

A study suggests that semaglutide, a medication used for type 2 diabetes and weight management, may reduce the risk of developing and relapsing into cannabis use disorder. The research, published in Molecular Psychiatry, utilized a large electronic health record database and found that semaglutide was associated with a reduced risk of new cannabis use disorder cases and a decreased likelihood of recurrence. While the study shows promise, further research, including randomized clinical trials, is needed to validate these findings and understand the underlying molecular mechanisms.

via PsyPost|

#addiction-treatment #cannabis-use-disorder #glp-1-receptor-agonist